investingLive Asia-pacific FX news wrap 20 Aug: NZD dumps on dovish RBNZ

Viking Therapeutics (VKTX) shorts pocket $514M as stock plunges 40% on failed weight-loss drug trial. High dropouts spook investors.

US deficits to hit $22.7T over decade; tariffs & spending add $4.6T, offset by $3.4T duties. Watch interest costs!

Supermarkets see 1.5% sales growth as consumers eat in; restaurants lag. Hellofresh sees 93% cooking more.

Viking Therapeutics (VKTX) stock plunges 40% on trial dropouts, lowering risk for rivals.

Bitcoin plunges amid inflation fears & Fed outlook. Liquidations swell as traders take profits. BTC dips, ETH falls, XRP gains.

China's oil sector overhaul targets 40% of plants for upgrades, phasing out smaller refiners to boost advanced materials.

NZ central bank cuts rates to 3.00%, flags more cuts. NZD/USD drops 0.8% to $0.5845. Traders eye growth headwinds.